期刊文献+

血清胱蛋白酶抑制剂C对评价狼疮性肾炎患者肾小球病理损害程度的价值 被引量:5

Significance of Serum Cystatin C in Evaluating the Degree of Glomerular Pathological Damage in Patients with Lupus Nephritis
下载PDF
导出
摘要 目的:探讨狼疮性肾炎患者血清胱蛋白酶抑制剂C(cystatin C)在评价肾小球病理损害程度中的价值。方法:选择狼疮性肾炎患者93例,入院后测定血清cystatin C,并行肾穿刺活检,对肾小球病理进行评分。分析cystatin C与肾小球病理评分的相关性,比较不同病理分级间cystatin C水平的差异。结果:血清cystatin C与狼疮性肾炎患者肾小球病理评分(r=0.7538,P=0.000)呈正相关,相关性具有统计学意义,肾小球病理1~3级间cystatin C水平的差异具有统计学意义(均P<0.01)。结论:血清cystatin C水平可以客观地评估狼疮性肾炎患者肾小球病理损害程度,是检测肾小球病理及功能改变的理想血清标志物。 Objective:To study the significance of serum cystatin C in evaluating the degree of glomerular pathological damage in patients with lupus nephritis.Methods:Serum cystatin C of 93 inpatients with lupus nephritis were measured by enzymed-linked immunosorbent assay,and tissue samples were harvested by percutaneous renal biopsies at the same time.The correlation between serum cystatin C and pathological scores of glomerulus,and the differences of serum cystatin C levels among the pathological classes for glomerulus were analyzed.Results:There was significance in correlation between serum cystatin C and pathological scores of glomerulus(r=0.753 8,P=0.000).Serum cystatin C among different pathological grades for glomerulus had very statistically significant differences(P〈0.01).Conclusion:Serum cystatin C can be used to evaluate objectively the degree of glomerular pathological damage,and might be an ideal serum marker for monitoring the impairment of glomerular pathology and function.
出处 《中国中西医结合肾病杂志》 2008年第6期524-526,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 狼疮性肾炎 血清胱蛋白酶抑制剂C 肾小球病理 Lupus nephritis Serum cystatin C Glomerular pathological damage
  • 相关文献

参考文献10

  • 1樊忠民,刘光陵,高远赋,夏正坤.61例儿童紫癜性肾炎临床病理分析[J].医学研究生学报,2000,13(B05):25-28. 被引量:10
  • 2Levey AS, Berg RL, Gassman JJ, et al. Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int, 1989,36(Suppl 27) :73 - 80.
  • 3Perrone RD, Madias NE,Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chin, 1992,38(10) : 1933 - 1953.
  • 4Newman DJ.Cystatin C.Ann Clin Biochem,2002,39(2) :89 - 104.
  • 5Tan GD,Altrnann P,Levis AV,et al. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes. Diabetes Care,2002,25(11) :2004 - 2009.
  • 6Rule AD, Bergstralh EJ, Slezak JM, et al. Glomenalar filtration rate estimated by eystatin C among different clinical presentations. Kidney Int,2006,69(2) : 399 - 405.
  • 7Menon V, Shlipak MG, Wang XL, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med, 2007,147(1) : 19 - 27.
  • 8李萍,赵莹,黄亨健,彭志英,徐克和.胱蛋白酶抑制剂C对肾小球滤过功能的评价[J].中华检验医学杂志,2005,28(5):515-516. 被引量:29
  • 9Newman DJ,Thakkar H, Edwards RG, et al. Serum eystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int, 1995,47 (2) :312 - 318.
  • 10Hojs R,Beve S,Ekart R,et al. Serum eystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant, 2006,21(7) :1855- 1862.

二级参考文献15

  • 1周柱亮,王亚平,汪建国.小儿和成人紫癜性肾炎的临床病理与疗效比较[J].综合临床医学,1994,10(1):14-15. 被引量:4
  • 2樊忠民,刘志红,陈惠萍,周虹,唐政,胡伟新,姚小丹,黎磊石.104例紫癜性肾炎临床病理及免疫病理的研究[J].肾脏病与透析肾移植杂志,1997,6(2):127-133. 被引量:27
  • 3Abrahamson M,Mason RW,Hansson H,et al. Human cystatin C.role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J, 1991,273:621-626.
  • 4Grubb A.Diagnostic value of analysis of cystatin and protein HC in biological fluids.Clin Nephol,1992,38 suppl 1:S 20-27
  • 5Ekiel I,Abrahamson M,Fulton DB,et al. NMR Structural studies of human cystatin C dimmers and monomers. J Mol Biol, 1997,271:266-277.
  • 6Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight protein for renal tubular uptake in experimental nephropathies. Nephron, 1994, 66:453-458.
  • 7Joronen I,Hopsu-Havu VK,Rinne A,et al. Detection of low molecular weight cysteine proteinase inhibitors by time-resolved fluoroimmunoassay. J Immunal Meth, 1986,86:243-247.
  • 8Colle A,Tavera C,Prevot D,et al. Cystatin C levels in sera of patein with human immunodeficiency virus infection. J immunoassay,1992,13:47-60.
  • 9Newman DJ.Cystatin C. Ann Clin biochem,2002,39:89-104.
  • 10Fanos V,Mussap M,Plebani M,et al. Cystatin C in paediatric nephrology, present situation and propect. Minerva Pediatr,1999,51:167-177.

共引文献37

同被引文献59

  • 1裘影影.狼疮性肾炎肾损害的临床表现与病理分析[J].江苏大学学报(医学版),2004,14(416):512-513. 被引量:3
  • 2李新蕊,赵田,胡俊,陈莺,杜华.4种尿微量蛋白联合检测狼疮性肾炎早期肾损伤的诊断价值[J].临床医药杂志,2005,18(1):35-37. 被引量:3
  • 3彭炎强,史伟,叶智明,梁馨苓,何朝生,章斌,王文健,梁永正.检测血清胱抑素C诊断急性肾衰竭的研究[J].新医学,2005,36(10):570-572. 被引量:23
  • 4王禹,刘晓丹,栗霄立,王力宁,周希静.亚临床狼疮肾炎的临床病理分析及随访[J].中华肾脏病杂志,2006,22(6):370-371. 被引量:4
  • 5Cooper GS, Treadwell EL, Stclair EW, et al. Sociodem ographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum ,2007,57 (6) :993 - 999.
  • 6Brunner HI, Gladman DD, Ibanez D, et al. Difference in disease features between childhood -onset and adult -onset systemic lupus erythematosus. Arthritis Rheum ,2008,58:556 - 562.
  • 7Hagelberg S, Lee Y, Bargman J, et al. Longterm followup of childhood lupus nephritis. J Rheumatol,2002 ,29 :2635 - 2642.
  • 8Tan GD, Ahmann P, Levis AV, et al. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type I diabetes. Dia- betes Care ,2002,25 ( 11 ) :2004 - 2009.
  • 9Rule AD, Bergstralh E.I, Slezak JM, et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int,2006,69 (2) :399 - 405.
  • 10Menon V, Shlipak MG,Wang XL,et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med,2007,147 (1) : 19 - 27.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部